Essentially, aspirin can boost the immune system’s ability to fight cancer metastasis by stopping platelets — tiny blood ...

This breakthrough paves the way for more accessible and targeted treatments. Aspirin works by inhibiting the production of thromboxane A2 (TXA2), a molecule produced by blood platelets. TXA2, known ...

Researchers found that aspirin decreases thromboxane A2 (TXA2) production, thus preventing T cell suppression and reducing the frequency of metastases in mice models. This discovery suggests a ...

Also read | Aspirin can reduce risk of heart attacks, strokes in pneumonia patients: Study The study observed that aspirin prevents cancers from spreading by decreasing TXA2 and releasing T cells ...

Despite advances in cancer treatment, many early-stage patients experience a recurrence when dormant cancer cells spread and grow into metastatic tumors. Scientists have now identified how aspirin ...

The study, published in Nature, found that, in mice, aspirin acted on platelets — the tiny cells that cause blood to clot — making them produce less of a clotting factor, thromboxane A2 (TXA2 ...

"New study shows aspirin may prevent cancer spread by enhancing immune system's ability to attack metastatic cells. Findings ...

They found that ARHGEF1 is switched on when T cells are exposed to a clotting factor called thromboxane A2 (TXA2) – this was an unexpected finding for the scientists. TXA2 is produced by platelets in ...